Varex Imaging Corp. (VREX)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$18.51-0.05%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · VREX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 844.6 | 844.6 | 844.6 | 811.0 | 893.4 | 859.4 | 738.3 | — | 780.6 | 773.4 | 698.1 |
| Total Revenues | — | — | — | 811.0 | 893.4 | 859.4 | 738.3 | — | 780.6 | 773.4 | 698.1 |
| Cost of Revenues | 554.1 | 554.1 | 554.1 | 554.1 | 603.1 | 575.9 | 548.1 | — | 523.9 | 519.5 | 444.6 |
| Gross Profit | 290.5 | 290.5 | 290.5 | 256.9 | 290.3 | 283.5 | 190.2 | — | 256.7 | 253.9 | 253.5 |
| Operating Expenses & Income | |||||||||||
| Selling, General & Admin | 133.3 | 133.3 | 133.3 | 137.8 | 128.4 | 118.3 | 142.2 | — | 128.1 | 123.4 | 102.5 |
| R&D Expenses | 91.1 | 91.1 | 91.1 | 87.0 | 84.8 | 77.0 | 78.9 | — | 78.1 | 83.0 | 67.3 |
| Operating Income | (27.8) | (27.8) | (27.8) | 32.1 | 77.1 | 88.2 | (33.7) | — | 45.7 | 44.5 | 83.7 |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | — | 35.5 | 30.2 | 29.3 | 39.8 | 31.4 | — | 21.1 | 21.7 | 12.3 |
| Interest & Investment Income | 8.5 | 8.5 | 8.5 | 7.3 | 3.7 | 0.4 | 0.1 | — | 0.1 | 0.2 | 0.2 |
| Net Interest Expenses | — | — | — | — | 25.6 | 39.4 | 31.3 | — | 21.0 | 21.5 | 12.1 |
| Other Non-Operating Income / Expenses | (31.4) | (31.4) | (31.4) | (27.1) | (45.8) | (43.7) | (38.9) | — | (24.2) | (18.8) | (8.9) |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | 0.0 |
| EBT, Incl. Unusual Items | (59.2) | (59.2) | (59.2) | 5.0 | 31.3 | 44.5 | (72.6) | — | 21.5 | 25.7 | 74.8 |
| Income Tax Expense | 10.7 | 10.7 | 10.7 | 52.2 | (16.6) | 13.7 | (15.2) | — | 5.7 | (2.6) | 22.8 |
| Net Income | |||||||||||
| Minority Interest | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | — | 0.3 | 0.8 | 0.4 |
| Net Income | (70.3) | (70.3) | (70.3) | (47.7) | 47.4 | 30.3 | (57.9) | — | 15.5 | 27.5 | 51.6 |
| Per Share | |||||||||||
| Basic EPS | — | (1.70) | (1.70) | (1.17) | 1.18 | 0.76 | (1.49) | — | 0.41 | 0.73 | 1.37 |
| Diluted EPS | — | (1.70) | (1.70) | (1.17) | 1.07 | 0.73 | (1.49) | — | 0.40 | 0.72 | 1.36 |
| Basic Weighted Avg Shares | — | 41.4 | 41.4 | 40.8 | 40.3 | 39.8 | 38.8 | — | 38.2 | 37.9 | 37.6 |
| Diluted Weighted Avg Shares | — | 41.4 | 41.4 | 40.8 | 50.3 | 41.6 | 38.8 | — | 38.6 | 38.4 | 38.0 |
| Supplemental | |||||||||||
| EBIT | (27.8) | (27.8) | (27.8) | 32.1 | 77.1 | 88.2 | (33.7) | — | 45.7 | 44.5 | 83.7 |
| Effective Tax Rate | -18.1% | -18.1% | — | — | -53.0% | 30.8% | 20.9% | — | 26.5% | -10.1% | 30.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.